Cassava Sciences Settles Securities Class Action for $31.25 Million
I'm PortAI, I can summarize articles.
Cassava Sciences Inc. has settled a securities class action for $31.25 million, resolving claims from plaintiffs who dealt with Cassava stock between September 2020 and October 2023. The settlement releases Cassava from related claims without admitting fault. The company had reserved the settlement amount as a loss contingency and plans to focus on developing simufilam for TSC-related epilepsy.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments